(Q30357308)

20 June 2017

title

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses. (English)

1 reference

20 June 2017

1 reference

Kristy Szretter

7

0 references

Larisa Rudenko

object named as

Larisa G Rudenko

9

0 references

Jacqueline M. Katz

11

object named as

Jacqueline M Katz

1 reference

20 June 2017

10

Alexander Klimov

1 reference

20 June 2017

8

Nancy J Cox

1 reference

20 June 2017

6

Iain Stephenson

1 reference

20 June 2017

Xiuhua Lu

1

1 reference

20 June 2017

Lindsay E Edwards

2

1 reference

20 June 2017

Julia A Desheva

3

1 reference

20 June 2017

Doan C Nguyen

4

1 reference

20 June 2017

Andrey Rekstin

5

1 reference

20 June 2017

language of work or name

English

0 references

publication date

5 June 2006

1 reference

20 June 2017

1 reference

20 June 2017

volume

24

1 reference

20 June 2017

issue

44-46

1 reference

20 June 2017

page(s)

6588-6593

1 reference

Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR.

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

The evolution of H5N1 influenza viruses in ducks in southern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Evolution of H5N1 avian influenza viruses in Asia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

inferred from DOI database lookup

7 January 2021

based on heuristic

A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.039

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.05.039

1 reference

20 June 2017

1 reference